Danaher Corporation $DHR Shares Sold by Vancity Investment Management Ltd

Vancity Investment Management Ltd cut its stake in Danaher Corporation (NYSE:DHR) by 5.4% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 91,357 shares of the conglomerate’s stock after selling 5,212 shares during the period. Danaher comprises about 2.6% of Vancity Investment Management Ltd’s holdings, making the stock its 11th largest holding. Vancity Investment Management Ltd’s holdings in Danaher were worth $17,402,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds have also recently bought and sold shares of the stock. JPL Wealth Management LLC purchased a new position in Danaher in the third quarter worth approximately $25,000. Main Street Group LTD acquired a new position in Danaher during the 1st quarter worth approximately $25,000. N.E.W. Advisory Services LLC purchased a new stake in shares of Danaher in the 2nd quarter valued at approximately $25,000. WFA of San Diego LLC purchased a new stake in shares of Danaher in the 2nd quarter valued at approximately $26,000. Finally, Hilton Head Capital Partners LLC acquired a new stake in shares of Danaher in the 4th quarter valued at $27,000. 79.05% of the stock is owned by institutional investors and hedge funds.

Danaher Stock Down 0.1%

Shares of NYSE:DHR opened at $207.46 on Monday. The firm has a 50 day simple moving average of $201.74 and a 200-day simple moving average of $192.14. Danaher Corporation has a twelve month low of $160.93 and a twelve month high of $242.80. The company has a current ratio of 1.65, a quick ratio of 1.25 and a debt-to-equity ratio of 0.48. The company has a market capitalization of $145.84 billion, a PE ratio of 36.85, a P/E/G ratio of 2.59 and a beta of 0.78.

Danaher (NYSE:DHR) last posted its earnings results on Monday, July 20th. The conglomerate reported $1.94 EPS for the quarter, beating analysts’ consensus estimates of $1.85 by $0.09. Danaher had a net margin of 15.95% and a return on equity of 11.04%. The firm had revenue of $6.26 billion for the quarter, compared to the consensus estimate of $6.12 billion. During the same period last year, the firm posted $0.77 EPS. The company’s revenue was up 5.5% on a year-over-year basis. On average, equities analysts predict that Danaher Corporation will post 8.53 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Several research firms have recently issued reports on DHR. TD Cowen decreased their price objective on shares of Danaher from $240.00 to $236.00 and set a “buy” rating for the company in a research report on Wednesday, July 22nd. DZ Bank began coverage on Danaher in a research note on Wednesday, June 3rd. They issued a “buy” rating and a $210.00 price target on the stock. Weiss Ratings raised Danaher from a “sell (d+)” rating to a “hold (c-)” rating in a report on Wednesday, July 15th. Wolfe Research cut Danaher from an “outperform” rating to a “peer perform” rating in a research report on Monday, June 1st. Finally, Deutsche Bank Aktiengesellschaft reiterated a “buy” rating and issued a $240.00 price objective on shares of Danaher in a report on Wednesday, July 22nd. One equities research analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating and five have given a Hold rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $228.91.

About Danaher

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.